Jun 10, 2026
The life sciences industry is in the midst of a quiet revolution, one that is unfolding not in sprawling clinical trial sites or blockbuster FDA approvals, but inside compact laboratory incubators where miniature, self-organizing replicas of human organs are being grown, monitored, and analyzed at unprecedented sca...
Read More...
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI
Mar 06, 2026
Newsletter/Whitepaper